tipiracil
Jump to navigation
Jump to search
Indications
- used in combination with trifluridine in the treatment of metastatic colorectal adenocarcinoma
Mechanism of action
- inhibits thymidine phosphorylase
More general terms
Component of
References
- ↑ Mayer RJ et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med 2015 May 14; 372:1909 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25970050 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1414325